Cell Point (India) Limited — Results, 29-05-2025: Integrated Filing- Financial
Cell Point (India) Limited has announced a board meeting on 29 May 2025 to approve the financial results for the quarter and half-year ended March 2025.
1) Revenue Performance: Total revenue was ₹3.25 Cr for the full year, up marginally from ₹3.21 Cr last year, driven by retail sales of smartphones, tablets, mobile accessories, and electronics in the domestic market.
2) Profitability and EPS: Net profit grew 33.5% to ₹2.26 Cr, with EPS rising to ₹12.10 from ₹9.70. Profitability improved due to better margin management, aided by cost rationalization and pricing strategies.
3) Operational Costs: Total expenses inched up slightly to ₹3.26 Cr from ₹3.20 Cr, with employee costs increasing modestly. Stable raw material and purchase costs indicate operational efficiency, though inventory changes held back results.
4) Key Metrics: Depreciation fell sharply from ₹0.19 Cr to ₹0.03 Cr following a method change, boosting profitability. Finance costs were also lower.
5) Balance Sheet / Cash Flow Health: Long-term debt reduced to ₹0.90 Cr from ₹1.11 Cr. Cash balances declined from ₹12 Cr to ₹6.44 Cr due to ₹4.99 Cr capex on fixed assets. Operating cash flow was negative at ₹0.69 Cr but partially offset by investing and financing activities.
6) Management Outlook: Focus remains on expanding the domestic retail business in smart tech with disciplined cost control. The switch to straight-line depreciation aims for clearer financial reporting.
Final Takeaway: Cell Point’s solid profit growth and EPS improvement reflect efficient cost management and operational gains. However, lower liquidity and negative operating cash flow suggest cautious monitoring. Retail investors can view momentum as stable with potential upside in retail expansion.
